Ipca Labs Q2 Profit Up 23% to Rs 283 Cr

By By Rediff Money Desk, New Delhi
Nov 13, 2025 15:58
Ipca Labs reports Q2 net profit of Rs 283 crore, a 23% increase YoY. Revenue rises to Rs 2,556 crore. Stock closes down 2.92% on BSE.
New Delhi, Nov 13 (PTI) Ipca Laboratories on Thursday posted a 23 per cent year-on-year increase in consolidated net profit at Rs 283 crore for the second quarter ended September 30, 2025.

The drug firm reported a net profit of Rs 229 crore for the July-September period of the last fiscal.

Revenue from operations rose to Rs 2,556 crore for the second quarter, as against Rs 2,355 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.

Shares of the company closed 2.92 per cent down at Rs 1,302.70 apiece on BSE.
Source: PTI
Read More On:
revenuenet profitq2 resultsipca laboratoriesrs 283 crore
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Unilever: India Growth & GST Impact

Unilever sees huge opportunities in India due to high GDP growth and GST cuts. HUL...

Trai Recommends 6 GHz, E, V Band Allocation

Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....

TotalEnergies Sells Stake in Adani Green Energy

TotalEnergies sells 1.74% stake in Adani Green Energy for Rs 2,778 cr. Stake reduced to...

TCS Acquires Coastal Cloud for $700 Million

TCS acquires Coastal Cloud for USD 700 million, strengthening its Salesforce and AI...

JSW Paints Acquires AkzoNobel India Stake

JSW Paints completes acquisition of majority stake in AkzoNobel India, becoming the...

Park Medi World IPO Subscribed 52% on Day 1

Park Medi World''s IPO received 52% subscription on day 1. The Rs 920-crore IPO closes...

Dasnac Invests Rs 2,000 Cr in Noida Luxury Housing

Dasnac to invest Rs 2,000 crore in a luxury housing project, Dasnac Westminster, in...

Nephrocare IPO Subscribed 12% on Day 1

Nephrocare Health Services IPO received 12% subscription on day 1. IPO details, price...

Wakefit IPO Subscribed Over 2 Times

Wakefit''s Rs 1,289-cr IPO was subscribed over 2 times on the final day. Details on...

IAN Group to Deploy USD 100M Alpha Fund by 2027

IAN Group to deploy its USD 100 million IAN Alpha Fund in early-stage startups by 2027....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com